Use of the tobacco mosaic virus platform to administer malaria antigens induces high and durable efficacy in macaques and individuals with an African-centric genetic variation may have an improved response to malaria.
Malaria antibodies in pregnant women may be a marker of exposure, not protection, from malaria and a combination of antimalarial drugs is less efficacious than if used in tandem.
Single-cell genome processing yields surprising results about the origin of complex malaria and study finds that the management of malaria in children at schools is ineffective.
A mechanism of resistance to artemisinin is identified and researchers find that breastfeeding could help to prevent malaria in babies.
Researchers from the Pasteur Institute discover molecules that can kill the malaria parasite and researchers from LSTM identify a resistance mechanism for insecticides used on bed nets.
Gene drives prove most efficient in the introduction of a transgene in populations of Anopheles stephensi mosquitoes.
Researchers from the Walter and Eliza Hall institute identify a new drug which blocks plasmepsin, a critical enzyme in gametocyte production.
The Gavi Alliance grant an additional $11.6 million in funding to extend clinical trials of the RTS,S vaccine.
The WHO publish their annual World Malaria Report which, this year, places emphasis on protecting pregnant women and children from malaria.
A genome of the European lineage of P. vivax malaria is generated by scientists and engineers develop an artificially-intelligent microscope for malaria diagnosis.